This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Kyorin Pharmaceutical Co., Ltd.. Active years: 2010-2018.
Company Filing History:
Years Active: 2010-2018
Title: Hidetaka Komatsu: Innovator in Pharmaceutical Crystallization
Introduction
Hidetaka Komatsu is a notable inventor based in Shimotsuga-gun, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of crystallization methods. With a total of 3 patents to his name, his work has advanced the efficiency and purity of pharmaceutical compounds.
Latest Patents
One of Hidetaka Komatsu's latest patents is a method for the crystallization of 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl]-1,3-propanediol hydrochloride. This innovative method allows for the highly efficient preparation of high-purity crystals of the compound. The process involves dissolving the compound in a mixed solvent that optimizes solubility, followed by the addition of hydrochloric acid to crystallize the hydrochloride form. This technique enhances the quality and yield of the desired pharmaceutical product.
Career Highlights
Hidetaka Komatsu is currently employed at Kyorin Pharmaceutical Co., Ltd., where he continues to develop and refine his innovative methods. His expertise in crystallization has positioned him as a key figure in the pharmaceutical industry, contributing to advancements that benefit both manufacturers and patients.
Collaborations
Throughout his career, Hidetaka has collaborated with esteemed colleagues such as Hiroya Satoh and Takeshi Tsubuki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Hidetaka Komatsu's contributions to the field of pharmaceutical crystallization exemplify the impact of innovative thinking in science. His methods not only improve the efficiency of drug production but also enhance the quality of pharmaceutical products available to consumers.